Jianfeng Xiao Selected Research

Inflammation (Inflammations)

1/2021

Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianfeng Xiao Research Topics

Disease

5	Dystonia (Limb Dystonia) 01/2022 - 08/2011
3	Neoplasms (Cancer) 10/2021 - 04/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 12/2019
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2021
2	Tremor (Tremors) 01/2018 - 11/2016
2	Myoclonic dystonia 02/2017 - 11/2003
1	Paraplegia (Spastic Paraplegia) 01/2022
1	Neuroinflammatory Diseases 01/2021
1	Gliosis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Catalepsy 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Genomic Instability 01/2019
1	Tardive Dyskinesia 01/2019
1	Epilepsy (Aura) 01/2018
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2018
1	Cognitive Dysfunction 05/2012
1	Primary Cervical Dystonia 04/2012
1	Ovarian Neoplasms (Ovarian Cancer) 04/2010
1	Breast Neoplasms (Breast Cancer) 04/2010
1	Dystonia musculorum deformans type 1 08/2004
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 11/2003
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 10/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 04/2010
2	Apoptosis Regulatory ProteinsIBA 10/2021 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2019
2	Sarcoglycans (beta Sarcoglycan)IBA 02/2017 - 11/2003
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	oligomycin sensitivity-conferring protein (complex V)IBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	3,16-dihydroxyandrost-5-ene-17,19-dioneIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Histones (Histone)IBA 01/2019
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Circulating Tumor DNAIBA 01/2018
1	Biological FactorsIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 02/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2016
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 06/2013
1	Levodopa (L Dopa)FDA LinkGeneric 05/2012
1	SolutionsIBA 04/2012
1	Phosphatidylethanolamine Binding ProteinIBA 04/2010
1	LigandsIBA 04/2010
1	Gap Junction beta-1 ProteinIBA 10/2002

Therapy/Procedure

2	Therapeutics 11/2020 - 01/2018
1	Deep Brain Stimulation 07/2013